Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
5.47
+0.04 (0.74%)
At close: Apr 2, 2026, 4:00 PM EDT
5.57
+0.10 (1.83%)
After-hours: Apr 2, 2026, 4:29 PM EDT
Inventiva Revenue
In the year 2025, Inventiva had annual revenue of 4.48M EUR, down -51.26%. Inventiva had revenue of 29.00K in the half year ending December 31, 2025, a decrease of -99.81%.
Revenue (ttm)
4.48M EUR
Revenue Growth
-51.26%
P/S Ratio
111.86
Revenue / Employee
53,369 EUR
Employees
84
Market Cap
1.04B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.48M | -4.72M | -51.26% |
| Dec 31, 2024 | 9.20M | -8.28M | -47.37% |
| Dec 31, 2023 | 17.48M | 5.30M | 43.50% |
| Dec 31, 2022 | 12.18M | 7.99M | 190.39% |
| Dec 31, 2021 | 4.19M | 3.82M | 1,027.42% |
| Dec 31, 2020 | 372.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 376.13M |
| Xeris Biopharma Holdings | 291.85M |
| Geron | 183.88M |
| CytomX Therapeutics | 76.20M |
| AbCellera Biologics | 75.13M |
| KalVista Pharmaceuticals | 73.62M |
| Septerna | 45.95M |
| EyePoint | 31.37M |
IVA News
- 21 hours ago - Inventiva SA (IVA) (Q4 2025) Earnings Call Highlights: Strategic Milestones and Financial ... - GuruFocus
- 22 hours ago - Full Year 2025 Inventiva SA Earnings Call Transcript - GuruFocus
- 2 days ago - Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 3 days ago - Inventiva reports 2025 full year results and provides a business update - GlobeNewsWire
- 10 days ago - Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results - GlobeNewsWire
- 14 days ago - Truist Securities Initiates Coverage on Inventiva (IVA) with a "Buy" Rating | IVA ... - GuruFocus
- 6 weeks ago - Inventiva reports preliminary 2025¹ fiscal year financial results - GlobeNewsWire
- 2 months ago - Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire